Tapewire

NYSE · USD

PHR

Phreesia, Inc.

Export transactions ↓
Tapewire entity
2606
SEC CIK
0001412408
Parsed reports
753

Last 12 months

Inside the activity.

6 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 2026021
Feb 202600
Mar 202643
Apr 202625
May 202601
Jun 202601
Jul 202603
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2021 Filed Jun 16, 2021 20:17 UTC
Roberts EvanChief Operating Officer
SaleCommon Stock 16,486 $55.91 $921,768.53
Disclosure

SEC source: 0001562180-21-004297 · primarydocument.xml · nonDerivative · entry 1

Roberts Evan · CIK 0001776704 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 611,622

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.36 to $56.34 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 20:17 UTC SaleCommon Stock 2,054 $57.90 $118,936.05
Disclosure

SEC source: 0001562180-21-004296 · primarydocument.xml · nonDerivative · entry 2

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,878

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.81 to $58.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 20:17 UTC SaleCommon Stock 12,946 $57.40 $743,101.69
Disclosure

SEC source: 0001562180-21-004296 · primarydocument.xml · nonDerivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,932

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.81 to $57.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 24, 2021 Filed May 26, 2021 20:24 UTC
Pegus CherylDirector
Tax withholdingCommon Stock 3,555 $45.45 $161,574.75
Disclosure

SEC source: 0001562180-21-003745 · primarydocument.xml · nonDerivative · entry 1

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,220

F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 12, 2021 Filed May 14, 2021 20:13 UTC SaleCommon Stock 100 $45.11 $4,511.00
Disclosure

SEC source: 0001562180-21-003484 · primarydocument.xml · nonDerivative · entry 2

Munson Gillian · CIK 0001592494 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,381

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 12, 2021 Filed May 14, 2021 20:13 UTC SaleCommon Stock 1,677 $44.39 $74,442.20
Disclosure

SEC source: 0001562180-21-003484 · primarydocument.xml · nonDerivative · entry 1

Munson Gillian · CIK 0001592494 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,481

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Linetsky DavidSVP, Life Sciences
Exercise / conversionStock Options (Right to buy) · Derivative 22,755 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001562180-21-003274 · primarydocument.xml · derivative · entry 4

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,755 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Linetsky DavidSVP, Life Sciences
Exercise / conversionStock Option · Derivative 22,755 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001562180-21-003274 · primarydocument.xml · derivative · entry 3

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,755 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Linetsky DavidSVP, Life Sciences
Exercise / conversionCommon Stock 22,755 $2.03 $46,192.65
Disclosure

SEC source: 0001562180-21-003274 · primarydocument.xml · nonDerivative · entry 2

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Linetsky DavidSVP, Life Sciences
Exercise / conversionCommon Stock 22,755 $0.84 $19,114.20
Disclosure

SEC source: 0001562180-21-003274 · primarydocument.xml · nonDerivative · entry 1

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,633

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Indig ChaimDirector · Chief Executive Officer
Exercise / conversionStock Options (Right to buy) · Derivative 123,750 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001562180-21-003273 · primarydocument.xml · derivative · entry 2

Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 123,750 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:54 UTC
Indig ChaimDirector · Chief Executive Officer
Exercise / conversionCommon Stock 123,750 $0.84 $103,950.00
Disclosure

SEC source: 0001562180-21-003273 · primarydocument.xml · nonDerivative · entry 1

Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,248,535

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:53 UTC
Roberts EvanChief Operating Officer
Exercise / conversionStock Options (Right to buy) · Derivative 25,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001562180-21-003272 · primarydocument.xml · derivative · entry 2

Roberts Evan · CIK 0001776704 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 25,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 04, 2021 Filed May 5, 2021 22:53 UTC
Roberts EvanChief Operating Officer
Exercise / conversionCommon Stock 25,000 $0.84 $21,000.00
Disclosure

SEC source: 0001562180-21-003272 · primarydocument.xml · nonDerivative · entry 1

Roberts Evan · CIK 0001776704 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 628,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC GrantCommon Stock 169 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003137 · primarydocument.xml · nonDerivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,878

F1 · shares: Granted as a result of director's election to receive deferred stock units in lieu of an annual cash retainer pursuant to the Issuer's Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of Phreesia, Inc. and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder or (ii) five years from the date of grant of the deferred stock units.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC GrantCommon Stock 169 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003136 · primarydocument.xml · nonDerivative · entry 1

Goldstein Lainie · CIK 0001399513 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,460

F1 · shares: Granted as a result of director's election to receive deferred stock units in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning fo Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

F2 · balance_after: These shares represent RSUs.

Read SEC document
April 30, 2021 Filed May 4, 2021 20:12 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionStock Options (Right to buy) · Derivative 5,688 $0.00 Strike: $8.03 $0.00
Disclosure

SEC source: 0001562180-21-003135 · primarydocument.xml · derivative · entry 2

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,689

Underlying: Common Stock · 5,688 shares

Expires 2029-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of this option vested and became exercisable on January 17, 2019, with the remainder vesting in three equal annual installments for the three years thereafter.

Read SEC document
April 30, 2021 Filed May 4, 2021 20:12 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionCommon Stock 5,688 $8.03 $45,674.64
Disclosure

SEC source: 0001562180-21-003135 · primarydocument.xml · nonDerivative · entry 1

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 17:08 UTC Exercise / conversionStock Options (Right to buy) · Derivative 2,134 $0.00 Strike: $4.71 $0.00
Disclosure

SEC source: 0001562180-21-002802 · primarydocument.xml · derivative · entry 4

Davidoff Michael J. · CIK 0001777450 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,111

Underlying: Common Stock · 2,134 shares

Expires 2028-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 17:08 UTC SaleCommon Stock 200 $51.52 $10,303.00
Disclosure

SEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 3

Davidoff Michael J. · CIK 0001777450 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,589

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.38 to $51.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 17:08 UTC SaleCommon Stock 1,934 $50.40 $97,481.14
Disclosure

SEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 2

Davidoff Michael J. · CIK 0001777450 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,789

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.08 to $50.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 17:08 UTC Exercise / conversionCommon Stock 2,134 $4.71 $10,051.14
Disclosure

SEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 1

Davidoff Michael J. · CIK 0001777450 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:28 UTC SaleCommon Stock 6,152 $55.22 $339,722.67
Disclosure

SEC source: 0001562180-21-002656 · primarydocument.xml · nonDerivative · entry 2

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,709

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.97 to $55.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:28 UTC SaleCommon Stock 8,848 $54.75 $484,392.61
Disclosure

SEC source: 0001562180-21-002656 · primarydocument.xml · nonDerivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,861

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.97 to $54.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 20:28 UTC
Linetsky DavidSVP, Life Sciences
SaleCommon Stock 300 $61.31 $18,393.00
Disclosure

SEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 5

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,580

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.07 to $61.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 20:28 UTC
Linetsky DavidSVP, Life Sciences
SaleCommon Stock 500 $60.62 $30,312.00
Disclosure

SEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 4

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,880

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.07 to $61.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 16, 2021 Filed Mar 17, 2021 20:28 UTC
Linetsky DavidSVP, Life Sciences
SaleCommon Stock 778 $58.51 $45,518.99
Disclosure

SEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 3

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,380

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.23 to $59.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:28 UTC
Linetsky DavidSVP, Life Sciences
SaleCommon Stock 6,706 $61.69 $413,721.31
Disclosure

SEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 2

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,158

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.50 to $62.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:28 UTC
Linetsky DavidSVP, Life Sciences
SaleCommon Stock 41,776 $61.06 $2,550,788.25
Disclosure

SEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 1

Linetsky David · CIK 0001776729 · SVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,864

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $61.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 19, 2021 Filed Feb 20, 2021 00:37 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 204 $73.39 $14,972.01
Disclosure

SEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 5

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,879

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.36 to $73.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 19, 2021 Filed Feb 20, 2021 00:37 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 700 $72.66 $50,862.07
Disclosure

SEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 4

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,083

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.28 to $72.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:51 UTC SaleCommon Stock 1,000 $73.56 $73,555.90
Disclosure

SEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 3

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,709

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.29 to $73.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:51 UTC SaleCommon Stock 882 $72.58 $64,012.91
Disclosure

SEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 2

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,709

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.26 to $73.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:51 UTC SaleCommon Stock 8,118 $71.75 $582,457.57
Disclosure

SEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,591

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.22 to $72.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:37 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 4,114 $73.51 $302,416.03
Disclosure

SEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 3

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,783

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.14 to $73.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:37 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 11,413 $72.37 $826,009.03
Disclosure

SEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 2

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,897

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.14 to $73.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 00:37 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 60,745 $71.77 $4,359,923.78
Disclosure

SEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 1

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,310

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.14 to $72.121 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · derivative · entry 8

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,387

Underlying: Common Stock · 500 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 17,704 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · derivative · entry 7

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,704 shares

Expires 2023-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
SaleCommon Stock 354 $67.44 $23,875.39
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 6

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,009

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.44 to $67.51 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
SaleCommon Stock 4,021 $66.79 $268,552.54
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 5

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,363

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.41 to $67.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
SaleCommon Stock 14,304 $65.81 $941,291.88
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 4

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,384

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.41 to $66.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
SaleCommon Stock 3,150 $65.09 $205,042.64
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 3

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,688

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.41 to $65.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionCommon Stock 500 $0.84 $420.00
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 2

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 21:34 UTC
VanDuyn Amy BethSVP, Human Resources
Exercise / conversionCommon Stock 17,704 $0.84 $14,871.36
Disclosure

SEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 1

VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,338

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 26, 2021 Filed Mar 17, 2025 20:36 UTC
Roberts EvanChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001127602-25-009698 · form5.xml · derivative · entry 2

Roberts Evan · CIK 0001776704 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 30,000 shares.

F2 · derivative.exercise_date: This option was fully vested and exercisable as of the date of the reported transaction.

Read SEC document
January 26, 2021 Filed Mar 17, 2025 20:36 UTC
Roberts EvanChief Operating Officer
Exercise / conversionCommon Stock 30,000 $0.84 $25,200.00
Disclosure

SEC source: 0001127602-25-009698 · form5.xml · nonDerivative · entry 1

Roberts Evan · CIK 0001776704 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 794,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 30,000 shares.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 22:50 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 719 $70.03 $50,351.79
Disclosure

SEC source: 0000899243-21-003334 · doc4.xml · nonDerivative · entry 2

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,055

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.77 to $70.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 22:50 UTC
Altier ThomasChief Financial Officer
SaleCommon Stock 776 $69.37 $53,832.28
Disclosure

SEC source: 0000899243-21-003334 · doc4.xml · nonDerivative · entry 1

Altier Thomas · CIK 0001777448 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,774

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.77 to $69.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 20, 2021 Filed Jan 22, 2021 22:34 UTC
Indig ChaimDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 14,892 $0.00 Strike: $4.71 $0.00
Disclosure

SEC source: 0000899243-21-002981 · doc4.xml · derivative · entry 5

Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,658

Underlying: Common Stock · 14,892 shares

Expires 2028-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · derivative.exercise_date: 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.